Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2002
09/26/2002US20020137205 Lipid uptake assays
09/26/2002US20020137204 Conditioned medium collected from a culture of feeder cells with laminin or collagen
09/26/2002US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it
09/26/2002US20020137197 For performing multiple diagnostic assays simultaneously, includes multiple stations, or modules, in which discrete aspects of the assay are performed on fluid samples contained in reaction receptacles
09/26/2002US20020137195 Contacting unoxidized carbon, silicon, or germanium substrate with a bromine- or iodine- containing reactant to form an unoxidized, bromine- or iodine-terminated carbon, silicon, or germanium substrate, reacting with alkene
09/26/2002US20020137194 Device for agitating the fluid contents of a container
09/26/2002US20020137193 Electrochemical affinity assay
09/26/2002US20020137190 High growth methanotrophic bacterial strain
09/26/2002US20020137189 Cardiac hypertrophy factor and uses therefor
09/26/2002US20020137184 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and use thereof
09/26/2002US20020137182 For obtaining and using a polypeptide other than oncogene BCL-2 that affects programmed vertebrate cell death
09/26/2002US20020137171 Nucleic acid encoding a polypeptide having hydrolase activity
09/26/2002US20020137166 ASIP-related proteins
09/26/2002US20020137151 Process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding for the sod gene
09/26/2002US20020137142 Tango-73 nucleic acids
09/26/2002US20020137137 Genetic engineering; polypeptides
09/26/2002US20020137135 Novel NPG-1 gene that is differentially expressed in prostate tumors
09/26/2002US20020137129 Polypeptides; genetic engineering; drug development
09/26/2002US20020137123 Colorfastness; pH indicator dye; monitoring efficiency
09/26/2002US20020137122 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria
09/26/2002US20020137121 Cell viability detection using electrical measurements
09/26/2002US20020137120 Diagnosis test; hypotensive agents; antidiabetic agents
09/26/2002US20020137119 Immunoassay; quantitative analysis
09/26/2002US20020137118 Drug desin
09/26/2002US20020137117 Support strips; pH indicator
09/26/2002US20020137115 Cgmp- visualizing probe and a method of detecting and quantifying of cgmp by using the same
09/26/2002US20020137113 Kinase receptor activation assay
09/26/2002US20020137110 Detecting apoptosis
09/26/2002US20020137108 CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's disease
09/26/2002US20020137106 Signal transduction
09/26/2002US20020137100 Method for determining the fertility of mammals, especially of humans
09/26/2002US20020137099 Repsiratory system disorders
09/26/2002US20020137096 Solid phase synthesis; photolithography
09/26/2002US20020137093 Method for continuous monitoring of chemical substances in fluids
09/26/2002US20020137090 Binding optical fibers
09/26/2002US20020137089 Methods of determining the presence of double stranded nucleic acids in a sample
09/26/2002US20020137088 Detecting Dna sequence in blood sampling; calibrating hybridization
09/26/2002US20020137087 Complexing; quantitative analysis
09/26/2002US20020137086 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes
09/26/2002US20020137085 Multiplexed generation of chemical or physical events
09/26/2002US20020137084 Method for detecting chemical interactions between naturally occurring biological analyte molecules
09/26/2002US20020137083 Gene detection chip and detection device
09/26/2002US20020137082 Calibration using chaperone protein
09/26/2002US20020137080 System and method for predicting chromosomal regions that control phenotypic traits
09/26/2002US20020137079 Analyzing polynucleotide sampling
09/26/2002US20020137078 Masking silicon substrates; blasting; oxidation; Dna immobilization substrate
09/26/2002US20020137074 Selectivity of nucleic acid diagnostic and microarray technologies by control of interfacial nucleic acid film chemistry
09/26/2002US20020137072 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/26/2002US20020137071 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/26/2002US20020137070 Colorimetric analysis
09/26/2002US20020137069 Beta 2 adrenergic polymorphism detection
09/26/2002US20020137067 Diagnosis of genetic disorders
09/26/2002US20020137066 Polynucleotide assay apparatus and polynucleotide assay method
09/26/2002US20020137064 Id-1 and Id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
09/26/2002US20020137062 Polymerase chain reactions
09/26/2002US20020137060 Combined hybridization-detection assays for determining nucleic acid concentrations in biological fluids
09/26/2002US20020137058 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/26/2002US20020137057 Detecting genes in biological sample; detector libraries
09/26/2002US20020137056 Calibration of signals
09/26/2002US20020137053 Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
09/26/2002US20020137052 System and apparatus for sequential processing of analytes
09/26/2002US20020137051 Detecting mutant genes
09/26/2002US20020137049 Pablo, a polypeptide that interacts with Bcl-xL, and uses related thereto
09/26/2002US20020137048 Gene coding
09/26/2002US20020137047 Amplification; polymerase chain reactions; sequence determination
09/26/2002US20020137046 Detection uisng mass spectrometry
09/26/2002US20020137043 Method for reducing complexity of nucleic acid samples
09/26/2002US20020137040 Polymorphism in p21 waf1/cip1 gene, association with human cancer and uses related thereto
09/26/2002US20020137039 High speed, accuracy; process control; polymerase chain reaction
09/26/2002US20020137038 Intestinal proteins
09/26/2002US20020137037 Cleavage of Dna, protein complex; chromatography
09/26/2002US20020137036 Polymerase chain reaction
09/26/2002US20020137035 Hybrid analyzing; tuberculosis diagnosis
09/26/2002US20020137034 Candida albicans two-component hybrid kinase gene, canik1, and use thereof
09/26/2002US20020137033 Veterinary medicine; analyzing animal Dna
09/26/2002US20020137032 Test device, measurement means, computers
09/26/2002US20020137031 Multidentate arrays
09/26/2002US20020137030 Method of detection of neoplastic cells
09/26/2002US20020137029 Identification of numerical changes in cell dna
09/26/2002US20020137028 Use of neuronal apoptosis inhibitor protein (naip)
09/26/2002US20020137027 Using optical indicator
09/26/2002US20020137026 Detection and characterization of microorganisms
09/26/2002US20020137021 Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
09/26/2002US20020137017 Method for detecting protein-protein interactions and a kit therefor
09/26/2002US20020136978 Transfer of arrayed chemical compositions
09/26/2002US20020136761 Ribonucleotide-oligonucleotide with a specific sequence that binds to both the negative and positive strands of influenza RNA
09/26/2002US20020136754 Recombinant bacterial phytases and uses thereof
09/26/2002US20020136730 From coagulase-negative bacteria produced in substantially pure form; use of purified adhesin product as vaccine for production of antibodies effective against binding of homologous bacterial cells to polymeric materials
09/26/2002US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family
09/26/2002US20020136720 Methods of using IMXP-888 and IMXP-888 antagonists
09/26/2002US20020136714 Relatedness of human interleukin-1beta convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
09/26/2002US20020136668 Jetting tube comprising orifice at one end and aperture at other end, transducer coupled with jetting tube and adapted to apply pressure pulse to tube in response to electrical signal; for separating and analyzing biomolecules
09/26/2002US20020134676 Biosensor and method of substrate quantification
09/26/2002DE10113876A1 Quantitative diagnosis of genetically related hypertension, by correlating blood pressure with overexpression or modification of human sgk family proteins
09/26/2002DE10113711A1 Identifying bio-chemical reactions e.g., DNA hybridization, comprises digitally scanning specific detector molecules in an array of accurately-defined and discrete points with a sample, for statistical evaluation
09/26/2002DE10110685A1 Oligonucleotide chip, useful for gene expression analysis of Saccharomyces cerevisiae, comprises an array of probes specific for S. cerevisiae open reading frames
09/26/2002DE10108680A1 Test strips for the assay of biological materials, for clinical diagnosis etc. carry affinity molecules and can take or support a flow to give time-related reactions
09/26/2002CA2852293A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom
09/26/2002CA2455354A1 Method of constructing cdna tag for identifying expressed gene and method of analyzing gene expression
09/26/2002CA2441813A1 Disease associated polymorphism in the ctla-4 locus